Sincrolab — Seed (estimated) · €100K

Eoniq Fund made a €100K follow-on (cumulative €335K) in Sincrolab's AI-prescribed cognitive-training therapeutics for ADHD and cognitive deficits.

LeadEoniq Fund RoundSeed (estimated) Announced19 Jun 2026 CityMadrid SectorHealthtech & Bio Source E

Something wrong? Suggest a correction →